Notes / Company Medicamen Biotech Ltd. MEDICAMEQ BSE 531146 ISIN INE646B01010 Pharmaceuticals Fundamentals Market cap₹386 cr P/E40.96× ROE3.08% Debt / equity0.16 Div yield0.37% 52-week range 216.95 — 448.80 The timeline — 1 note on Medicamen Biotech Ltd. May 2026 27 May 26 · 3:29 PM IST Brief Brief · Earnings · Micro cap Medicamen Biotech reports flat standalone profit for FY26 The pharmaceutical firm posted consolidated profit of ₹979.64 lacs, while standalone profit remained nearly flat at ₹940.87 lacs. Verify on exchange BSE filings for MEDICAMEQ NSE filings for MEDICAMEQ